免疫荧光检测市场 - 增长、趋势、COVID-19 影响和预测(2022 - 2027 年)

市场按产品(试剂和试剂盒、仪器、耗材和配件)、类型、应用和地理位置进行细分。

市场快照

Immunofluorescence Assay Market Analysis
Study Period: 2018 - 2026
Base Year: 2021
Fastest Growing Market: Asia Pacific
Largest Market: North America
CAGR: 5.8 %
Immunofluorescence Assay Market Major Players

Need a report that reflects how COVID-19 has impacted this market and its growth?

市场概况

研究的免疫荧光检测市场预计在预测期内以近 5.8% 的复合年增长率增长。导致市场增长的主要因素是大肠疾病的发病率增加,如肠癌、憩室炎、克罗恩病、溃疡性结肠炎和炎症性肠病。根据美国科学促进会 (AAAS) 的数据,患有炎症性肠病的人数是之前估计的三倍,患者患结直肠癌的风险也更高,影响了欧洲超过 300 万人. 此外,可引流造口袋的日益普及和对产品开发的投资增加正在推动市场增长。然而,

报告范围

根据报告的范围,免疫荧光是特异性抗原和抗体反应,其中抗体用荧光染料标记,抗原-抗体复合物使用荧光显微镜观察。该报告按程序、类型、应用程序和地理位置细分。

By Product
Reagents and Kits
Instruments
Consumables & Accessories
By Type
Indirect Immunofluorescence
Direct Immunofluorescence
By Application
Cancer
Infectious Diseases
Autoimmune Diseases
Others
Geography
North America
United States
Canada
Mexico
Europe
Germany
United Kingdom
France
Italy
Spain
Rest of Europe
Asia-Pacific
China
Japan
India
Australia
South Korea
Rest of Asia-Pacific
Middle East and Africa
GCC
South Africa
Rest of Middle-East and Africa
South America
Brazil
Argentina
Rest of South America

Report scope can be customized per your requirements. Click here.

主要市场趋势

间接免疫荧光细分市场主导着免疫荧光检测市场。

  • 间接免疫荧光的优点是灵敏度高,在改变二抗的基础上容易改变信号颜色,可商业化。方便地获得标记的第二抗体。与一抗相比,二抗相对便宜。通过使用相同的偶联二抗检测不同的一抗,可以进一步节省成本。
  • 除了上述因素外,其他促进细分市场增长的因素是癌症和传染病的发病率增加,这些检测方法用于诊断。根据世界卫生组织的数据,预计 2018 年全球癌症负担将上升至 1810 万新病例和 960 万人死亡。全球五分之一的男性和六分之一的女性在其一生中患上癌症,八分之一的男性和每 11 名妇女中就有 1 名死于这种疾病。此外,生物技术公司对研发项目的投资不断增加,推动了该领域的增长。
Immunofluorescence Assay Market Growth

北美在市场上占主导地位,预计在预测期内也会如此

在整个预测期内,预计北美将主导整个市场。市场增长是由于主要参与者的存在、该地区传染病和癌症的高发病率、成熟的医疗保健基础设施等因素导致其在市场上占有很大份额的一些关键因素。此外,有益的政府举措和研究合作伙伴数量的增加是预计会增加市场增长的一些驱动因素。由于支持性医疗保健政策、大量患者和发达的医疗保健市场,美国在该地区的份额最大。根据美国国立卫生研究院 (NIH) 的数据,2018 年,美国估计将发现 1,735,350 例新的癌症病例,609,640 人将死于该病。

Immunofluorescence Assay Market Share

竞争格局

免疫荧光检测市场竞争适度,由几个主要参与者组成。目前主导市场的一些公司是 Thermo Fisher、Inova Diagnostics, Inc.、Bio-Rad Laboratories, Inc.、Abcam、PerkinElmer Inc.、Merck Millipore、Cell Signaling Technology、MEDIPAN GMBH、Sino Biological、Danaher。

Table of Contents

  1. 1. INTRODUCTION

    1. 1.1 Study Assumptions and Market Defintion

    2. 1.2 Scope of the Study

  2. 2. RESEARCH METHODOLOGY

  3. 3. EXECUTIVE SUMMARY

  4. 4. MARKET DYNAMICS

    1. 4.1 Market Overview

    2. 4.2 Market Drivers

      1. 4.2.1 Increasing Incidence of Cancer and Other Infectious Diseases

      2. 4.2.2 Growing Investments By Government and Non-government Organizations

    3. 4.3 Market Restraints

      1. 4.3.1 Upsurge of Alternative Tests Which are More Effective

    4. 4.4 Porter's Five Force Analysis

      1. 4.4.1 Threat of New Entrants

      2. 4.4.2 Bargaining Power of Buyers/Consumers

      3. 4.4.3 Bargaining Power of Suppliers

      4. 4.4.4 Threat of Substitute Products

      5. 4.4.5 Intensity of Competitive Rivalry

  5. 5. MARKET SEGMENTATION

    1. 5.1 By Product

      1. 5.1.1 Reagents and Kits

      2. 5.1.2 Instruments

      3. 5.1.3 Consumables & Accessories

    2. 5.2 By Type

      1. 5.2.1 Indirect Immunofluorescence

      2. 5.2.2 Direct Immunofluorescence

    3. 5.3 By Application

      1. 5.3.1 Cancer

      2. 5.3.2 Infectious Diseases

      3. 5.3.3 Autoimmune Diseases

      4. 5.3.4 Others

    4. 5.4 Geography

      1. 5.4.1 North America

        1. 5.4.1.1 United States

        2. 5.4.1.2 Canada

        3. 5.4.1.3 Mexico

      2. 5.4.2 Europe

        1. 5.4.2.1 Germany

        2. 5.4.2.2 United Kingdom

        3. 5.4.2.3 France

        4. 5.4.2.4 Italy

        5. 5.4.2.5 Spain

        6. 5.4.2.6 Rest of Europe

      3. 5.4.3 Asia-Pacific

        1. 5.4.3.1 China

        2. 5.4.3.2 Japan

        3. 5.4.3.3 India

        4. 5.4.3.4 Australia

        5. 5.4.3.5 South Korea

        6. 5.4.3.6 Rest of Asia-Pacific

      4. 5.4.4 Middle East and Africa

        1. 5.4.4.1 GCC

        2. 5.4.4.2 South Africa

        3. 5.4.4.3 Rest of Middle-East and Africa

      5. 5.4.5 South America

        1. 5.4.5.1 Brazil

        2. 5.4.5.2 Argentina

        3. 5.4.5.3 Rest of South America

  6. 6. COMPETITIVE LANDSCAPE

    1. 6.1 Company Profiles

      1. 6.1.1 Thermo Fisher Scientific Inc.

      2. 6.1.2 Inova Diagnostics, Inc.

      3. 6.1.3 Bio-Rad Laboratories, Inc.

      4. 6.1.4 Abcam

      5. 6.1.5 PerkinElmer Inc.

      6. 6.1.6 Merck Millipore

      7. 6.1.7 Cell Signaling Technology

      8. 6.1.8 MEDIPAN GMBH

      9. 6.1.9 Sino Biological

      10. 6.1.10 Danaher Corporation

    2. *List Not Exhaustive
  7. 7. MARKET OPPORTUNITIES AND FUTURE TRENDS

**Subject to Availability
**Competitive Landscape covers- Business Overview, Financials, Products and Strategies and Recent Developments

You can also purchase parts of this report. Do you want to check out a section wise price list?

Frequently Asked Questions

The Immunofluorescence Assay Market market is studied from 2018 - 2026.

The Immunofluorescence Assay Market is growing at a CAGR of 5.8% over the next 5 years.

Asia Pacific is growing at the highest CAGR over 2021- 2026.

North America holds highest share in 2021.

Thermo Fisher, Inova Diagnostics, Inc., Bio-Rad Laboratories, Inc., Abcam, PerkinElmer Inc. are the major companies operating in Immunofluorescence Assay Market.

80% of our clients seek made-to-order reports. How do you want us to tailor yours?

Please enter a valid email id!

Please enter a valid message!